← Eichor
Condition: Glioblastoma Multiforme Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Glioblastoma Multiforme

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT00083512Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Phase 1 · 1 location(s) · Beijing Biotech · NCT07480941Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
Phase 2 · 1 location(s) · Tianjin Medical University General Hospital · NCT06327451Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma
Phase 1 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT05083754Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma
NA · 1 location(s) · Erasmus Medical Center · NCT06183983Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab
Phase 2 · 1 location(s) · Duke University · NCT06816927Anti-GD2 ADC M3554 in Advanced Solid Tumors
Phase 1 · 11 location(s) · EMD Serono Research & Development Institute, Inc. · NCT06641908[177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma
EARLY_Phase 1 · 2 location(s) · Beijing Tiantan Hospital · NCT07655869Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors
Phase 1 · 2 location(s) · Chipscreen Biosciences, Ltd. · NCT06902350Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
Phase 1 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05366179A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
Phase 1 · 3 location(s) · RasCal Therapeutics, Inc. · NCT04678648Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Gl
Phase 1/Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT06059690The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
Phase N/A · 8 location(s) · Erasmus Medical Center · NCT04708171HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Phase 1/Phase 2 · 1 location(s) · The Methodist Hospital Research Institute · NCT03603405Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread
Phase 2 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07193654Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared
Phase 3 · 1 location(s) · Northwell Health · NCT05271240Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.
NA · 1 location(s) · Jules Bordet Institute · NCT07119294Imaging Acetadote Metabolism in Glioblastoma
EARLY_Phase 1 · 1 location(s) · University of Texas Southwestern Medical Center · NCT07387666Pilot Trial for Treatment of Recurrent Glioblastoma
EARLY_Phase 1 · 1 location(s) · AHS Cancer Control Alberta · NCT054325185G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
Phase 1/Phase 2 · 3 location(s) · Institute of Cancer Research, United Kingdom · NCT06630260Evaluate the Efficacy and Safety of ADCV01 As an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients
Phase 2 · 3 location(s) · Ever Supreme Bio Technology Co., Ltd. · NCT04115761MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment
NA · 1 location(s) · Shengjing Hospital · NCT05957679Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Tr
Phase 2 · 12 location(s) · ECOG-ACRIN Cancer Research Group · NCT06319027WBSI Guided Personalized Delivery of TTFields
NA · 2 location(s) · Abramson Cancer Center at Penn Medicine · NCT05086497Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Ref
Phase 2 · 1 location(s) · Northwell Health · NCT028004865G-PEARL: Paxalisib in Malignant Brain Tumours
Phase 1/Phase 2 · 1 location(s) · Institute of Cancer Research, United Kingdom · NCT07391215ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV G
Phase 1 · 2 location(s) · Jonsson Comprehensive Cancer Center · NCT07089641PH Sensitive MRI Based Resections of Glioblastoma
Phase 1 · 1 location(s) · University of California, Los Angeles · NCT06176066Drug Response Testing and Repurposing Using Glioblastoma Organoid
Phase N/A · 1 location(s) · Chungnam National University Hospital · NCT06782984A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combinatio
Phase 2 · 5 location(s) · Cedars-Sinai Medical Center · NCT05708352
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.